Navigation Links
Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
Date:11/10/2011

CRANBURY, N.J., Nov. 10, 2011 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) will announce its first quarter, fiscal year 2012 financial results on Tuesday, November 15, 2011 before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November 15, 2011, which will include discussion of the results of operations in greater detail and an update on corporate developments.Schedule for the Financial Results Press Release, Conference Call / Webcast-
Q1 Fiscal Year 2012 Financial Results Press Release11/15/2011 at 7:30 a.m. ET-
Q1 Fiscal Year 2012 Conference Call-Live

11/15/2011 at 11:00 a.m. ETDomestic Dial-In Number

1-888-256-1007International Dial-In Number

1-913-312-1466Pass code

3249586-
Q1 Fiscal Year 2012 Conference Call-Replay

11/15-11/22/2011Domestic Dial-In Number

1-888-203-1112International Dial-In Number

1-719-457-0820Pass code

3249586-
Webcast Live and Replay Access

http://www.palatin.comThe webcast and replay can be accessed by logging on to the "Investor/Media Center-Webcasts"

section of Palatin's website at http://www.palatin.comAbout Palatin Technologies, Inc.Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin's website at www.palatin.com.

Palatin Technologies Investor Inquiries:Palatin Technologies Media Inquiries:Stephen T. Wills, CPA, MST

Carney Noensie, Burns McClellanChief Operating Officer / Chief Financial OfficerVice President, Investor RelationsTel: (609) 495-2200 / info@palatin.com

Tel: (212) 213-0006 / cnoensie@burnsmc.com
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Palatin Technologies to Present at 10th Annual BIO Investor Forum
2. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results
3. Palatin Technologies, Inc. to Report Fiscal Year 2011 Fourth Quarter Results; Teleconference and Webcast to be held on September 22, 2011
4. Palatin Technologies, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference
5. Palatin Announces Commencement of a Phase 1 Trial for Obesity Compound in Collaboration with AstraZeneca
6. Palatin Technologies, Inc. Announces Presentation and Publication on Validation of Scale for Subjective Male Sexual Arousal
7. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2011 Results
8. Palatin Technologies, Inc. Announces Results of Annual Stockholders Meeting
9. Palatin Technologies, Inc. to Present at the ROTH 23rd Annual OC Growth Stock Conference
10. Palatin Technologies, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
11. Palatin Technologies, Inc. Announces Proposed Public Offering of Common Stock and Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Ca (PRWEB) , ... February 22, 2017 , ... ... events for tech innovators, engineers, and scientists from around the world, is pleased ... place on February 22 and 23, 2017. This premier, online-only conference focused on ...
(Date:2/22/2017)... Dublin - Research ... Crop Protection (Bio-Pesticide) Market-By Type, By Application, By End User, By ... offering. ... Biological Crop Protection Market is forecasted to grow at a CAGR ... biopesticide or biological crop protection market is driven by the surging ...
(Date:2/22/2017)... 22, 2017 Aethlon Medical, Inc. (Nasdaq: ... study that validated the ability of the Aethlon Hemopurifier® ... increased mortality in immune-suppressed sepsis patients and also contribute ... The objective of the study was to validate the ... virus (EBV) and Herpes Simplex virus 1 (HSV1) by ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pharma and biotech ... as European director. Operating from Pennside’s Zurich headquarters, Pennside Partners, GmbH, Mr. Perkins ... Pennside after more than a decade with leading market research firm, GfK. He ...
Breaking Biology Technology:
(Date:1/21/2017)... DUBLIN , Jan 20, 2017 Research ... Recognition Biometrics Market 2017-2021" report to their offering. ... The global voice recognition ... period 2017-2021. The report covers the present scenario ... for 2017-2021. To calculate the market size, the report considers the ...
(Date:1/19/2017)... , Jan. 19, 2017 Sensory ... experience and security for consumer electronics, and ... processing systems and cybersecurity solutions, today announced a ... and financial institutions worldwide to bolster security of ... end-to-end secure user authentication platforms they offer, innerCore ...
(Date:1/18/2017)... Jan. 18, 2017 MedNet Solutions ... supports the entire spectrum of clinical research, is ... record-breaking year for the organization in terms of ... MedNet,s eClinical products and services. The company,s exceptional ... success of iMedNet ™ ...
Breaking Biology News(10 mins):